The FDA issued about 100 warning letters to pharmaceutical companies and healthcare providers, including major drugmakers and telehealth firms, to stop or modify misleading drug advertisements, signaling an aggressive regulatory push despite concerns over resource limitations.
The FDA has issued multiple warning letters to pharmaceutical companies, including Eli Lilly and Novo Nordisk, for misleading drug advertisements across various media, emphasizing concerns over safety disclosures and the portrayal of drugs in a way that may mislead consumers, as part of a broader crackdown on deceptive marketing practices in the industry.
Advertisements for Air France, Lufthansa, and Etihad have been banned by the Advertising Standards Authority (ASA) for misleading consumers about the airlines' environmental credentials. The ads claimed commitments to protecting the environment and flying more sustainably, but the ASA found that the claims were not adequately substantiated. Air travel's high levels of CO2 and non-CO2 emissions contribute significantly to climate change, and the ASA stated that there are currently no initiatives or technologies in the aviation industry that can fully support absolute green claims. The airlines have been instructed not to run the ads again.
Google has earned over $10 million in the past two years by allowing misleading advertisements for "fake" abortion clinics that aim to stop women from having the procedure, according to a report from the Center for Countering Digital Hate. The report identified 188 fake clinic websites that placed ads on Google, estimating that ads for fake clinics were clicked on by users 13 million times during this period. Google requires any organization that wants to advertise to people seeking information about abortion services to be certified and clearly disclose whether they do or do not offer abortions.